BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27836106)

  • 1. Preoperative platelet count improves the prognostic prediction of the FIGO staging system for operable cervical cancer patients.
    Zheng RR; Huang XX; Jin C; Zhuang XX; Ye LC; Zheng FY; Lin F
    Clin Chim Acta; 2017 Oct; 473():198-203. PubMed ID: 27836106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
    Deng Q; Long Q; Liu Y; Yang Z; Du Y; Chen X
    BMC Cancer; 2021 Nov; 21(1):1282. PubMed ID: 34844568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
    Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
    Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.
    Liu X; Wang W; Hu K; Zhang F; Hou X; Yan J; Meng Q; Zhou Z; Miao Z; Guan H; Ma J; Shen J; Zhen H; Wang W
    Sci Rep; 2020 Jan; 10(1):362. PubMed ID: 31941966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a surgical-pathologic staging and scoring system for cervical cancer.
    Li S; Li X; Zhang Y; Zhou H; Tang F; Jia Y; Hu T; Sun H; Yang R; Chen Y; Cheng X; Lv W; Wu L; Zhou J; Wang S; Huang K; Wang L; Yao Y; Yang Q; Yang X; Zhang Q; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Shen J; Xi L; Li K; Deng D; Wang H; Wang C; Wu M; Zhu T; Chen G; Gao Q; Wang S; Hu J; Kong B; Xie X; Ma D
    Oncotarget; 2016 Apr; 7(15):21054-63. PubMed ID: 27014971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
    Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer.
    Widschwendter P; Janni W; Scholz C; De Gregorio A; De Gregorio N; Friedl TWP
    Arch Gynecol Obstet; 2019 Dec; 300(6):1709-1718. PubMed ID: 31696367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
    Zhang W; Yu H; Xiu Y; Meng F; Wang Z; Zhao K; Wang Y; Chen Z; Liu J; Chen J; Sun B
    Technol Cancer Res Treat; 2024; 23():15330338241254075. PubMed ID: 38720626
    [No Abstract]   [Full Text] [Related]  

  • 11. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
    Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
    Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
    Akkas BE; Demirel BB; Dizman A; Vural GU
    Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Tang X; Guo C; Liu S; Guo J; Hua K; Qiu J
    Int J Gynaecol Obstet; 2021 Oct; 155(1):86-94. PubMed ID: 33587753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer systemic inflammation score: a novel predictor of prognosis.
    Zheng RR; Huang M; Jin C; Wang HC; Yu JT; Zeng LC; Zheng FY; Lin F
    Oncotarget; 2016 Mar; 7(12):15230-42. PubMed ID: 26885692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer.
    Yang S; Liu Y; Xia B; Deng J; Liu T; Li Q; Yang Y; Wang Y; Ning X; Zhang Y; Xiao M
    Tumour Biol; 2016 Apr; 37(4):5063-74. PubMed ID: 26546434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
    Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
    Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.